Long non‐coding RNAs (lncRNAs) have emerged as important regulators of cancer, including colorectal cancer (CRC). The exact expression pattern of long intergenic noncoding RNA 00312 (LINC00312) in CRC and its mechanisms of action have not been reported. Here, we found that LINC00312 is underexpressed in CRC tissues and cell lines. Functional experiments suggested that LINC00312 suppresses growth, migration and invasion of CRC cells in vitro and attenuates tumour proliferation and metastasis in vivo. Mechanistically, LINC00312 was found to regulate the malignancy of CRC cells by binding to miR‐21 and by functioning as a tumour suppressor targeting PTEN. Overexpression of miR‐21 or knockdown of PTEN attenuated the LINC00312‐mediated inhibition of CRC cell proliferation and invasion. Taken together, our results elucidate the role of the LINC00312–miR‐21–PTEN axis in CRC cell proliferation and tumour progression and may lead to new lncRNA‐based diagnostics or therapeutics for CRC.
Different from phased-array radar, frequency diverse array (FDA) radar offers range-dependent beampattern and thus provides new application potentials. But there is a fundamental question: what estimation performance can achieve for an FDA radar? In this paper, we derive FDA radar Cramér-Rao lower bounds (CRLBs) for estimating direction, range (time delay), and velocity (Doppler shift). Two different data models including pre- and postmatched filtering are investigated separately. As the FDA radar has range-angle coupling, we use a simple transmit subaperturing strategy which divides the whole array into two subarrays, each uses a distinct frequency increment. Assuming temporally white Gaussian noise and linear frequency modulated transmit signal, extensive simulation examples are performed. When compared to conventional phased-array radar, FDA can yield better CRLBs for estimating the direction, range, and velocity. Moreover, the impacts of the element number and frequency increment are also analyzed. Simulation results show that the CRLBs decrease with the increase of the elements number and frequency increment.
Colorectal cancer (CRC) affects people globally and lymph node metastasis (LNM) is an important indicator of poor clinical outcome in CRC. The current study aims to evaluate the role of microRNA-448 (miR-488) and claudin-2 (CLDN2) in epithelial-mesenchymal transition (EMT) and LNM of CRC through the MAPK signaling pathway. Firstly, microarray analysis indicated that MiR-488 was poorly expressed in CRC, whereas CLDN2 was highly expressed. Additionally, the bioinformatics website MicroRNA.org, and the dual luciferase reporter gene assay found that CLDN2 was a target gene of miR-488. Next, the results for the correlations between expression of miR-488 and clinicopathological characteristics of CRC indicated that the expression of miR-488 was closely associated with differentiation degree, LNM, and Dukes stages in CRC patients. Moreover, over-expression of miR-488 inhibited the activation of the MAPK signal transduction pathway. Notably, loss- and gain- of-function experiments demonstrated that up-regulation of miR-488 suppressed SW480 cell viability, invasion, and migration, and promoted apoptosis in SW480 cells. Finally, over-expression of miR-488 inhibited LNM, MLVD, and tumor growth in nude mice. We conclude that over-expression of miR-488 could suppress the cell proliferation, EMT, and LNM of CRC cells via inhibition of CLDN2-mediated MAPK signaling pathway, which could be a new molecular therapy target for CRC.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.